Streetbeat News

Stock Prices

WEN

Analysts have provided various ratings for Wendy's (NASDAQ:WEN) within the last quarter, with 2 bullish, 6 somewhat bullish, and 5 indifferent. The average 12-month price target for Wendy's is $25.42, a decrease of 4.08% from the previous average price target of $26.50.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

ULCC

Over the past 3 months, 12 analysts have published their opinion on Frontier Group Holdings (NASDAQ:ULCC) stock. The average price target for the stock is $9.29, a decrease of 30.93% from the previous average price target of $13.45. The analysts are evenly split between somewhat bullish and indifferent stances.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

SHAK

In the last quarter, Shake Shack (NYSE:SHAK) has received 14 analyst ratings, with 3 being bullish, 1 somewhat bullish, and 10 indifferent. Over the past 3 months, 14 analysts have offered 12-month price targets for Shake Shack, with an average price target of $76.71, an increase of 8.21% from the previous average price target of $70.89.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

PLUG

Plug Power CEO Andy Marsh appeared on CNBC to discuss the company's projections and the day's stock movement following revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:53 pm

ADBE

Adobe shares are trading higher amid the Adobe MAX conference this week.

Portfolio Pulse from Bill Haddad

October 11, 2023 | 6:51 pm

AU

GFI

HMY

MUX

Shares of gold companies are trading higher as gold prices rise due to conflict in the Middle East, which is causing a flight to safe-haven assets.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:47 pm

LRCX

A significant investor has taken a bearish stance on Lam Research (NASDAQ:LRCX), with 63% of recent trades being bearish. The targeted price range for Lam Research over the last 3 months is $530.0 to $645.0. The current price of LRCX is up 0.72% at $638.94. Wolfe Research has downgraded its action to Outperform with a price target of $825, while UBS maintains their Buy rating with a price target of $725.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:46 pm

ABBV

A significant bearish stance has been taken on AbbVie (NYSE:ABBV) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 8% bullish and 91% bearish. The whales have been targeting a price range from $55.0 to $150.0 for AbbVie over the last 3 months. Morgan Stanley maintains an Overweight rating on AbbVie with a price target of $193, while Raymond James downgraded its action to Outperform with a price target of $177.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 6:46 pm

SPOT

Piper Sandler analyst Matt Farrell reiterated a Neutral rating on Spotify Technology S.A. (NYSE:SPOT) with a price target of $150. Investors have warmed up to the conservatism in the Q3 subscriber guidance following disappointing net add assumptions. Farrell noted that the price increase only impacts one month of Q3 but will fully impact Q4. He remains on the sidelines heading into the earnings announcement, seeking further clarity on subscriber trends, incremental levers for gross and operating margin, and any signs of an advertising inflection.

Portfolio Pulse from Anusuya Lahiri

October 11, 2023 | 6:35 pm

CZR

MGM

Stifel analyst Steven M. Wieczynski has reiterated a Buy rating on Caesars Entertainment, Inc. (NASDAQ:CZR), raising the price target to $80 from $74. The recent sell-off due to cyber-attacks has created a compelling entry point for CZR. The analyst highlights multiple catalysts that should drive shares higher and believes the long-term impact of the cyber-attacks should be minimal. The analyst also raised FY23E EPS to $4.12 from $3.98, with revenues of $11.56 billion.

Portfolio Pulse from Nabaparna Bhattacharya

October 11, 2023 | 6:35 pm